A Placebo- and Midazolam-Controlled, Phase Ia, Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam Tosylate
Phase of Trial: Phase I
Latest Information Update: 05 Feb 2018
At a glance
- Drugs Remimazolam (Primary) ; Midazolam
- Indications Anaesthesia; Sedation
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Jiangsu Hengrui Medicine Co.
- 30 Jan 2018 Status changed from recruiting to completed.
- 05 Nov 2013 New trial record